• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药剂师对用药理由信息价值的看法。

Pharmacists' perspectives on the value of reason for use information.

作者信息

Whaley Colin, Bancsi Ashley, Burns Catherine, Grindrod Kelly

机构信息

School of Pharmacy (Whaley, Bancsi, Grindrod), Faculty of Engineering, Waterloo, Ontario.

Faculty of Science and the Department of Systems Design Engineering (Burns), Faculty of Engineering, Waterloo, Ontario.

出版信息

Can Pharm J (Ott). 2020 Aug 18;153(5):294-300. doi: 10.1177/1715163520946052. eCollection 2020 Sep-Oct.

DOI:10.1177/1715163520946052
PMID:33110470
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7560559/
Abstract

BACKGROUND

The indication for a particular medication, or its reason for use (RFU), is important information for prescribers, pharmacists and patients but is not often communicated in writing from prescribers to pharmacists. Adding RFU to a prescription and a medication label would ensure that pharmacists are confident that they are providing high-quality, accurate patient care. This study aims to describe the perspectives of pharmacists on how receiving RFU from prescribers would affect their practice and how pharmacists putting this information on prescriptions would affect patients.

METHODS

Semi-structured qualitative interviews were conducted with 20 pharmacists in Southwestern Ontario. Thematic analysis was used to analyze the interview transcripts, leading to 4 major themes.

RESULTS

Pharmacists expressed that RFU should be formatted to ensure that it is of clinical utility via the use of written text and noted that either medical or lay (also known as ) language would be appropriate for use. Pharmacists indicated that patient privacy should be considered when writing RFU on labels and that patient preference with respect to the addition of RFU should dictate its inclusion on a medication label. Pharmacist access to RFU was universally acknowledged to improve patient safety by providing pharmacists with more information to determine whether the given medication was indicated.

CONCLUSIONS

This study provides further information about the impact that having access to RFU would have on pharmacy practice and can be used to advocate for the inclusion of RFU information with prescriptions to improve patient outcomes. 2020;153:xx-xx.

摘要

背景

特定药物的适应证,即其用药理由(RFU),对于开处方者、药剂师和患者来说都是重要信息,但开处方者通常不会以书面形式将其传达给药剂师。在处方和药品标签上添加RFU将确保药剂师确信他们提供的是高质量、准确的患者护理。本研究旨在描述药剂师对于从开处方者处接收RFU将如何影响其工作以及药剂师将此信息写在处方上会如何影响患者的看法。

方法

对安大略省西南部的20名药剂师进行了半结构化定性访谈。采用主题分析法对访谈记录进行分析,得出4个主要主题。

结果

药剂师表示,RFU应采用书面文本形式进行格式化,以确保其具有临床实用性,并指出医学语言或通俗语言(也称为外行语言)都适合使用。药剂师指出,在标签上书写RFU时应考虑患者隐私,并且患者对于添加RFU的偏好应决定其是否包含在药品标签上。普遍认为药剂师获取RFU可通过为药剂师提供更多信息来确定所给药物是否适用,从而提高患者安全。

结论

本研究提供了关于获取RFU对药学实践影响的更多信息,可用于倡导在处方中包含RFU信息以改善患者结局。2020年;153:xx - xx。

相似文献

1
Pharmacists' perspectives on the value of reason for use information.药剂师对用药理由信息价值的看法。
Can Pharm J (Ott). 2020 Aug 18;153(5):294-300. doi: 10.1177/1715163520946052. eCollection 2020 Sep-Oct.
2
Prescribers' perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysis.医生对在处方和药品标签上加入用药原因信息的看法:一项定性主题分析。
BMC Health Serv Res. 2021 Jan 26;21(1):89. doi: 10.1186/s12913-021-06103-1.
3
How do I keep myself safe? Patient perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysis.我如何保护自己的安全?患者对在处方和药品标签上包含用药原因信息的看法:一项定性主题分析。
J Pharm Policy Pract. 2020 Oct 7;13:63. doi: 10.1186/s40545-020-00268-6. eCollection 2020.
4
Reason for Use: An Opportunity to Improve Patient Safety.使用原因:提升患者安全的契机。
Stud Health Technol Inform. 2019;257:47-52.
5
What do Australian consumers, pharmacists and prescribers think about documenting indications on prescriptions and dispensed medicines labels?: A qualitative study.澳大利亚消费者、药剂师和开处方者对在处方和配药标签上记录适应症有何看法?一项定性研究。
BMC Health Serv Res. 2017 Nov 15;17(1):734. doi: 10.1186/s12913-017-2704-3.
6
Pharmacists and patients feedback on empirically designed prescription warning labels: a qualitative study.药剂师和患者对经验设计处方警示标签的反馈:一项定性研究。
Int J Clin Pharm. 2017 Feb;39(1):187-195. doi: 10.1007/s11096-016-0421-3. Epub 2017 Jan 9.
7
Syntax Error: Variations in the Verbiage of Prescription Labels for Pediatric Liquid Medications.语法错误:儿科液体药物处方标签措辞的差异
Cureus. 2024 Mar 12;16(3):e56039. doi: 10.7759/cureus.56039. eCollection 2024 Mar.
8
Exploring pharmacy service users' support for and willingness to use community pharmacist prescribing services.探讨药剂服务使用者对社区药剂师处方服务的支持和使用意愿。
Res Social Adm Pharm. 2019 May;15(5):575-583. doi: 10.1016/j.sapharm.2018.07.016. Epub 2018 Jul 24.
9
Initial perceptions of key stakeholders in Ontario regarding independent prescriptive authority for pharmacists.安大略省主要利益相关者对药剂师独立处方权的初步看法。
Res Social Adm Pharm. 2014 Mar-Apr;10(2):341-54. doi: 10.1016/j.sapharm.2013.05.008. Epub 2013 Jun 28.
10
Prescriber and pharmacist attitudes toward inclusion of diagnosis or clinical indication on prescription orders.医生和药剂师对在处方上添加诊断或临床指征的态度。
J Am Pharm Assoc (2003). 2021 Jul-Aug;61(4):e284-e288. doi: 10.1016/j.japh.2020.12.015. Epub 2021 Feb 6.

引用本文的文献

1
Protocols versus practice: unravelling clinical checking variations in community pharmacies in England-a multi-method study.方案与实践:揭示英格兰社区药店临床核对差异——一项多方法研究。
Int J Clin Pharm. 2024 Oct;46(5):1114-1123. doi: 10.1007/s11096-024-01743-9. Epub 2024 Jun 1.
2
Incorporating 'reason for use' into the prescribing process of medication: a survey on the opinion of patients in Flanders, Belgium.将“用药理由”纳入药物处方流程:比利时佛兰德斯地区患者意见调查。
BMC Health Serv Res. 2022 Sep 30;22(1):1216. doi: 10.1186/s12913-022-08596-w.
3
Prescribers' perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysis.医生对在处方和药品标签上加入用药原因信息的看法:一项定性主题分析。
BMC Health Serv Res. 2021 Jan 26;21(1):89. doi: 10.1186/s12913-021-06103-1.

本文引用的文献

1
Comparison of a Prototype for Indications-Based Prescribing With 2 Commercial Prescribing Systems.基于适应证的处方原型与 2 种商业处方系统的比较。
JAMA Netw Open. 2019 Mar 1;2(3):e191514. doi: 10.1001/jamanetworkopen.2019.1514.
2
Reason for Use: An Opportunity to Improve Patient Safety.使用原因:提升患者安全的契机。
Stud Health Technol Inform. 2019;257:47-52.
3
A Prescription For Enhancing Electronic Prescribing Safety.增强电子处方安全的处方。
Health Aff (Millwood). 2018 Nov;37(11):1877-1883. doi: 10.1377/hlthaff.2018.0725.
4
Saturation in qualitative research: exploring its conceptualization and operationalization.定性研究中的饱和度:探索其概念化与操作化
Qual Quant. 2018;52(4):1893-1907. doi: 10.1007/s11135-017-0574-8. Epub 2017 Sep 14.
5
Incorporating medication indications into the prescribing process.将用药指征纳入处方开具流程。
Am J Health Syst Pharm. 2018 Jun 1;75(11):774-783. doi: 10.2146/ajhp170346. Epub 2018 Apr 19.
6
A Patient-Centered Prescription Drug Label to Promote Appropriate Medication Use and Adherence.一份以患者为中心的处方药标签,以促进合理用药和依从性。
J Gen Intern Med. 2016 Dec;31(12):1482-1489. doi: 10.1007/s11606-016-3816-x. Epub 2016 Aug 19.
7
Medication management of febrile children: a qualitative study on pharmacy employees' experiences.发热儿童的药物管理:关于药房工作人员经验的定性研究
Int J Clin Pharm. 2016 Oct;38(5):1200-9. doi: 10.1007/s11096-016-0353-y. Epub 2016 Jul 23.
8
Factors contributing to the identification and prevention of incorrect drug prescribing errors in outpatient setting.导致门诊环境下药物处方错误识别和预防的因素。
Saudi Pharm J. 2014 Nov;22(5):429-32. doi: 10.1016/j.jsps.2013.11.003. Epub 2013 Nov 19.
9
Standards for reporting qualitative research: a synthesis of recommendations.报告定性研究的标准:建议的综合。
Acad Med. 2014 Sep;89(9):1245-51. doi: 10.1097/ACM.0000000000000388.
10
Assessing the effect of providing a pharmacist with patient diagnosis on electronic prescription orders: a pilot study.评估为药师提供患者诊断信息对电子处方医嘱的影响:一项试点研究。
Res Social Adm Pharm. 2014 Jan-Feb;10(1):246-51. doi: 10.1016/j.sapharm.2013.04.010. Epub 2013 May 17.